16 Dec 2022 Oxurion announces the continuation of KALAHARI Phase 2, Part B Study in diabetic macular edema following interim analysis Member news
09 Dec 2022 UCB announces positive Phase 3 studies for bimekizumab in hidradenitis suppurativa Member news
21 Nov 2022 Oxurion: Interim analysis for KALAHARI trial planned by year-end 2022 with full top-line data expected in second half of 2023 Member news
15 Nov 2022 Rejuvenate Biomed’s newly appointed Clinical Advisory Board endorses Clinical Phase 2b strategy in sarcopenia Member news
15 Nov 2022 Sequana Medical announces positive top-line results from SAHARA Ph. 2a study of DSR 1.0 in diuretic-resistant heart failure patients with persistent congestion and first patient dosed successfully with DSR 2.0 in YUKON Member news
25 Oct 2022 Sequana Medical announces positive top-line results from the North American pivotal alfapump® study (POSEIDON) Member news
12 Oct 2022 Mithra announces positive preclinical data demonstrating Estetrol’s efficacy in wound healing Member news
29 Sep 2022 Indigo Diabetes announces first participant enrolled in the SHINE clinical trial Member news
31 Aug 2022 reMYND identifies novel target and small molecules with potential to halt and reverse disease progression in Huntington’s disease through oral administration Member news
01 Aug 2022 Celyad Oncology announces FDA lifts clinical hold of CYAD-101-002 Phase 1b trial Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us
